Non-invasive Prenatal Screening
The DISCOVER™ test, from Lab Solutions, represents a major advance in prenatal testing, providing accurate answers about fetal chromosomal health without the risks associated with invasive procedures.
What is DISCOVER™
The DISCOVER™ prenatal test is a simple—noninvasive blood test that screens for the most common chromosomal abnormalities that can affect an infant’s future health. The DISCOVER™ test is available for both singleton and twin pregnancies. Test results are usually reported back to your healthcare provider within approximately one week’s time.
The Discover Process
A sample of blood is drawn and the genetic material (DNA) from mother and baby is tested. The DISCOVER™ test takes a deeper approach to the science, using an advanced technology called “Massively Parallel Sequencing” to analyze millions of DNA fragments per sample and accurately count the number of chromosomes present. It then uses a special SAFeR TM calculation method to determine if there are too many or too few copies of these chromosomes in the infant.
Who to Test?
The DISCOVER™ test offers parents-to-be a new choice to obtain important information about the health of their developing baby, simply, accurately and in the first trimester (at 10 weeks), with little or no risk to their pregnancy.
This screening test is usually offered to pregnant women identified by their doctor to have a chance of fetal aneuploidy. It may be an option for you to consider if you have a confirmed singleton or twin pregnancy of at least 10 weeks’ gestational age, and meet any of the following criteria:
Patient is considered to be of advanced maternal age at time of delivery (35 years or older for a singleton pregnancy or 32 years or older for a twin pregnancy)
Patient ultrasound shows concerns or abnormalities with fetal growth and/or development
Patient has a personal or family history suggestive of trisomies 21, 18, 13, or other sex chromosome aneuploidies
Patient has an abnormal or “positive” serum screen
What do DISCOVER™ results indicate?
Results tell the provider whether or not trisomies 21, 18, 13 or sex chromosome abnormalities (if ordered) are highly likely to be present in pregnancy. In the case of a positive result, the provider will discuss what the results mean to your pregnancy as well as further testing options to consider.
Your test report will include one of three possible results for chromosomes 21, 18, and 13:
• No Aneuploidy Detected—means the expected number of chromosomes was found
• Aneuploidy Detected—means too many or too few copies of one of the chromosomes have been identified. This can indicate a chromosome abnormality. Your provider may advise a diagnostic test for confirmation
COMMITTED TO RESEARCH
With its superior technology, the DISCOVER™ test provides clinical evidence showing across-the-whole genome analysis in a real-world population. The performance of the DISCOVER™ prenatal test was evaluated in a major scientific study in which more than 60 leading US medical research and teaching institutions participated.
LabSolutions continues to expand the technology with its commitment to sponsor and support continued clinical studies to advance the effectiveness of NIPT (non-invasive prenatal testing).
The reassurance of reliable answers— simply, safely, sooner.
A simple, in-office blood test
Safe from procedural risks of invasive procedures (amniocentesis/CVS)
Lowest test failure rate among non-invasive prenatal tests
Fast results—usually available to your doctor within 2 – 4 business days